It is widely accepted that generation of tumor specific CD8+ T-cell responses occur via cross-priming; however the source of tumor antigen for this event is unknown. We examined the source and formof tumor antigen required for crosspresentation in the local lymph node (LN) using a syngeneic mouse tumor model expressing a marker antigen. We found that cross-presentation of this model tumor antigenin the LN is dependent on continuous traffic of antigen from the tumor site, but without any detectable migration of tumor resident dendritic cells (DCs). Instead, small numbers of tumor cells metastasize to local LNs where they are exposed to a localized CTL attack, resulting in delivery of tumor antigen into the cross-presentation pathway. © 2012 Landes Bioscience.
CITATION STYLE
McDonnell, A. M., Currie, A. J., Brown, M., Kania, K., Wylie, B., Cleaver, A., … Robinson, B. W. S. (2012). Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation. OncoImmunology, 1(6), 840–846. https://doi.org/10.4161/onci.20493
Mendeley helps you to discover research relevant for your work.